Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016

IMPORTANCE: To date, the risk of developing second primary cancers (SPCs) after the first primary melanoma has not been studied in the era of immune checkpoint inhibitors (ICIs). OBJECTIVE: To assess differences in the risk of SPCs in patients with primary melanoma before (2005-2010) and after (2011...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Weiye, Wang, Yifan, Liu, Xiangyu, Liu, Jieqiong, Wang, Liang, Yang, Zhaogang, Yang, Mingming, An, Yi, Tang, Chad, Sanford, Nina N., Kim, Betty Y. S., Jiang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726633/
https://www.ncbi.nlm.nih.gov/pubmed/33295975
http://dx.doi.org/10.1001/jamanetworkopen.2020.28627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726633/
https://www.ncbi.nlm.nih.gov/pubmed/33295975
http://dx.doi.org/10.1001/jamanetworkopen.2020.28627

Ejemplares similares